The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development

Area of Science:

• Dermatology
• Oncology
• Immunology

Background:

• Solar UV irradiation is a primary carcinogen responsible for most human cancers, specifically skin cancer.
• The specific receptors mediating UV-induced skin carcinogenesis remain largely unidentified.
• Cannabinoid receptors (CB1/2) are known to play roles in various physiological processes, but their involvement in UV carcinogenesis is unclear.

Purpose of the Study:

• To identify the receptors involved in UV-induced skin carcinogenesis.
• To investigate the role of cannabinoid receptors 1 and 2 (CB1/2) in UV-induced skin inflammation and cancer development.

Main Methods:

• Directly assessing the activation of CB1/2 receptors by UV irradiation.
• Utilizing genetically modified mice lacking CB1/2 receptors to study their response to UVB exposure.
• Analyzing the activation of key signaling pathways, including mitogen-activated protein kinases (MAPK) and nuclear factor-kappaB (NF-κB), in response to UVB.

Main Results:

• UV irradiation was shown to directly activate cannabinoid receptors 1 and 2 (CB1/2).
• Mice deficient in CB1/2 receptors exhibited significant resistance to UVB-induced inflammation and a substantial reduction in skin carcinogenesis.
• CB1/2 deficiency led to attenuated activation of MAPK and NF-κB pathways following UVB exposure.

Conclusions:

• Cannabinoid receptors 1 and 2 (CB1/2) are directly activated by UV irradiation.
• CB1/2 receptors play a critical role in mediating UV-induced skin inflammation and promoting skin cancer development.
• Targeting CB1/2 receptors may offer a novel therapeutic strategy for preventing or treating UV-induced skin cancer.